mirtazapine has been researched along with HIV Infections in 8 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine use was safe and well tolerated." | 2.74 | Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. ( Cettomai, D; McArthur, JC, 2009) |
| "Treatment with mirtazapine 30 mg orally daily and mefloquine hydrochloride 250 mg orally for three days, then 250 mg weekly, was initiated." | 1.38 | Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus. ( Jett, RA; Moenster, RP, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, F | 1 |
| Sheeler, D | 1 |
| Hotton, A | 1 |
| Vecchio, ND | 1 |
| Flores, R | 1 |
| Fujimoto, K | 1 |
| Harawa, N | 1 |
| Schneider, JA | 1 |
| Khanna, AS | 1 |
| Cifci, B | 1 |
| Yildiz, Y | 1 |
| Altin, E | 1 |
| Habibi, H | 1 |
| Kocer, B | 1 |
| Dizbay, M | 1 |
| Coffin, PO | 1 |
| Santos, GM | 1 |
| Hern, J | 1 |
| Vittinghoff, E | 1 |
| Walker, JE | 1 |
| Matheson, T | 1 |
| Santos, D | 1 |
| Colfax, G | 1 |
| Batki, SL | 1 |
| Iannetta, M | 1 |
| Bellizzi, A | 1 |
| Lo Menzo, S | 1 |
| Anzivino, E | 1 |
| D'Abramo, A | 1 |
| Oliva, A | 1 |
| D'Agostino, C | 1 |
| d'Ettorre, G | 1 |
| Pietropaolo, V | 1 |
| Vullo, V | 1 |
| Ciardi, MR | 1 |
| Loignon, M | 1 |
| Toma, E | 1 |
| Cettomai, D | 1 |
| McArthur, JC | 1 |
| Mischo, M | 1 |
| Nigg, C | 1 |
| Kiss, A | 1 |
| Moenster, RP | 1 |
| Jett, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM: a 6-month Randomized Controlled Trial With 3 Months of Follow-up[NCT01888835] | Phase 2 | 120 participants (Actual) | Interventional | 2013-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for mirtazapine and HIV Infections
| Article | Year |
|---|---|
Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Coinfection; Cy | 2016 |
[Depression].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; C | 2010 |
2 trials available for mirtazapine and HIV Infections
| Article | Year |
|---|---|
Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.
Topics: Adult; Amphetamine-Related Disorders; Double-Blind Method; Female; HIV Infections; Homosexuality, Ma | 2020 |
Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy.
Topics: Adult; Blood-Brain Barrier; Brain; Drug Administration Schedule; Early Diagnosis; Female; HIV Infect | 2009 |
4 other studies available for mirtazapine and HIV Infections
| Article | Year |
|---|---|
Stimulant use interventions may strengthen 'Getting to Zero' HIV elimination initiatives in Illinois: Insights from a modeling study.
Topics: Central Nervous System Stimulants; HIV Infections; Homosexuality, Male; Humans; Illinois; Male; Meth | 2022 |
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report.
Topics: HIV Infections; Humans; Immunoglobulins, Intravenous; JC Virus; Leukoencephalopathy, Progressive Mul | 2023 |
HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Topics: Adrenal Cortex Hormones; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Fatal | 2013 |
Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus.
Topics: Cognition Disorders; Histamine H1 Antagonists; HIV Infections; Humans; JC Virus; Leukoencephalopathy | 2012 |